Drug Shortage Report for POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR
| Report ID | 168276 |
| Drug Identification Number | 00786306 |
| Brand name | POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR |
| Common or Proper name | POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE |
| Strength(s) | 300MG 900MG 5G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000mL (2B2454X) |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-09-02 |
| Actual start date | 2022-09-02 |
| Estimated end date | 2022-11-01 |
| Actual end date | 2022-11-01 |
| Shortage status | Resolved |
| Updated date | 2022-11-02 |
| Company comments | We have identified four alternative Baxter codes for your consideration if aligned to clinical practice: JB1674, JB1434, JB1264, and JB1984 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-11-02 | English | Compare |
| v7 | 2022-10-28 | French | Compare |
| v6 | 2022-10-28 | English | Compare |
| v5 | 2022-10-06 | French | Compare |
| v4 | 2022-10-06 | English | Compare |
| v3 | 2022-09-03 | English | Compare |
| v2 | 2022-08-31 | French | Compare |
| v1 | 2022-08-31 | English | Compare |
Showing 1 to 8 of 8